First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended by NICE ...

Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins. NHS England ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

The new modifier was introduced in 2022 to allow extra weight to be given to medicines that address severe diseases. It ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Mental wellbeing is about life satisfaction, optimism, self-esteem, feeling in control, having a purpose and a sense of belonging and support. Older people, including those living in care homes, often ...

Our guidance helps people in the NHS make efficient, cost-effective and consistent decisions about adopting new medical technologies. It supports innovation and transformation and improves healthcare ...

Medicines support for adults may be provided by a number of different people, including family, healthcare professionals and homecare staff. It is essential to be clear about what support is needed ...

All NICE products on physical activity. Includes any guidance and quality standards.

Elacestrant for treating oestrogen receptor-positive, HER2-negative advanced breast cancer with an ESR1 mutation after at least 1 endocrine treatment [ID6225] Draft guidance Technology appraisal ...